Cardiff Oncology shares plunge after Q2 earnings miss
Investing.com -- Unitedhealth Group (NYSE:UNH) stock tumbled more than 5% in premarket trading Tuesday after the company offered a disappointing profit guidance and missed the earnings per share (EPS) forecasts in the second quarter.
The health insurer reported Q2 EPS of $4.08, falling short of analysts’ expectations of $4.45. Quarterly revenue rose to $111.62 billion, slightly above the consensus forecast of $111.59 billion.
“UnitedHealth Group has embarked on a rigorous path back to being a high-performing company fully serving the health needs of individuals and society broadly,” said Stephen Hemsley, CEO of UnitedHealth Group.
For the full year 2025, the company projects earnings of $16.00 per share, well below the $20.90 expected by analysts. Revenue guidance was set between $445.5 billion and $448 billion, compared to the consensus estimate of $449.1 billion.
UnitedHealth said the new guidance "reflects first half 2025 performance and expectations for the remainder of the year, including higher realized and anticipated care trends."
"The company expects to return to earnings growth in 2026," it added.